-+ 0.00%
-+ 0.00%
-+ 0.00%

EUPRAXIA PHARMACEUTICALS ANNOUNCES SUSTAINED POSITIVE TREATMENT OUTCOMES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) AFTER NINE MONTHS OF RECEIVING EP-104GI

Reuters·05/05/2025 11:00:02

Please log in to view news